This content is in French.
Gadolinium-based contrast agents in the follow-up of primary brain tumors
12 février 2024
Gadolinium-based contrast agents are used at all stages of MRI evaluation of primary brain tumors. Although they do not precisely measure tumor grade, they are regularly used for diagnosis and…
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Ivar J H G Wamelink et al. Brain Tumor Imaging without Gadolinium-based Contrast Agents: Feasible or Fantasy? Radiology. 2024 Feb;310(2):e230793.
View the source
